196 related articles for article (PubMed ID: 24956560)
1. Association of PARP-1, NF-κB, NF-κBIA and IL-6, IL-1β and TNF-α with Graves Disease and Graves Ophthalmopathy.
Niyazoglu M; Baykara O; Koc A; Aydoğdu P; Onaran I; Dellal FD; Tasan E; Sultuybek GK
Gene; 2014 Sep; 547(2):226-32. PubMed ID: 24956560
[TBL] [Abstract][Full Text] [Related]
2. Poly (ADP-ribose) polymerase-1 (PARP-1) in Chinese patients with Graves' disease and Graves' ophthalmopathy.
Wu T; Tang DR; Zhao L; Sun FY
Can J Physiol Pharmacol; 2018 Jun; 96(6):556-561. PubMed ID: 28177666
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism of the NFKB1 affects the serum inflammatory levels of IL-6 in Hashimoto thyroiditis in a Turkish population.
Koc A; Batar B; Celik O; Onaran I; Tasan E; Sultuybek GK
Immunobiology; 2014 Jul; 219(7):531-6. PubMed ID: 24703107
[TBL] [Abstract][Full Text] [Related]
4. Activation and overexpression of PARP-1 in circulating mononuclear cells promote TNF-alpha and IL-6 expression in patients with unstable angina.
Huang D; Yang CZ; Yao L; Wang Y; Liao YH; Huang K
Arch Med Res; 2008 Nov; 39(8):775-84. PubMed ID: 18996291
[TBL] [Abstract][Full Text] [Related]
5. Graves' ophthalmopathy and gene polymorphisms in interleukin-1alpha, interleukin-1beta, interleukin-1 receptor and interleukin-1 receptor antagonist.
Khalilzadeh O; Anvari M; Esteghamati A; Mahmoudi M; Tahvildari M; Rashidi A; Khosravi F; Amirzargar A
Clin Exp Ophthalmol; 2009 Aug; 37(6):614-9. PubMed ID: 19702713
[TBL] [Abstract][Full Text] [Related]
6. Association between interleukin-6 polymorphism and age-at-onset of type 1 diabetes. Epistatic influences of the tumor necrosis factor-alpha and interleukin-1beta polymorphisms.
Hermann C; Krikovszky D; Füst G; Kovács M; Körner A; Szabó A; Vannay A; Madácsy L
Eur Cytokine Netw; 2005 Dec; 16(4):277-81. PubMed ID: 16464741
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms of endothelin 1 (G5665T and T-1370G) and endothelin receptor type A (C+70G and G-231A) in Graves' disease.
Aydın AF; Develi-İş S; Doğru-Abbasoğlu S; Vural P; Ozderya A; Karadağ B; Uysal M
Int Immunopharmacol; 2014 Jan; 18(1):198-202. PubMed ID: 24291390
[TBL] [Abstract][Full Text] [Related]
8. Genetic susceptibility to Graves' ophthalmopathy: the role of polymorphisms in proinflammatory cytokine genes.
Anvari M; Khalilzadeh O; Esteghamati A; Esfahani SA; Rashidi A; Etemadi A; Mahmoudi M; Amirzargar AA
Eye (Lond); 2010 Jun; 24(6):1058-63. PubMed ID: 19798110
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor-α and interleukin-1β gene polymorphisms and risk of brain abscess in North Indian population.
Mishra P; Prasad KN; Singh K; Bajpai A; Sahu RN; Ojha BK
Cytokine; 2015 Sep; 75(1):159-64. PubMed ID: 26187330
[TBL] [Abstract][Full Text] [Related]
10. Influence of the TSH receptor gene on susceptibility to Graves' disease and Graves' ophthalmopathy.
Yin X; Latif R; Bahn R; Tomer Y; Davies TF
Thyroid; 2008 Nov; 18(11):1201-6. PubMed ID: 18925838
[TBL] [Abstract][Full Text] [Related]
11. The VDR gene confers a genetic predisposition to Graves' disease and Graves' ophthalmopathy in the Southwest Chinese Han population.
Zhou F; Liang Z; Wang X; Tan G; Wei W; Zheng G; Ma X; Tian D; Li H; Yu H
Gene; 2021 Aug; 793():145750. PubMed ID: 34077777
[TBL] [Abstract][Full Text] [Related]
12. Platelet-derived growth factor-BB: a stimulus for cytokine production by orbital fibroblasts in Graves' ophthalmopathy.
van Steensel L; Paridaens D; Dingjan GM; van Daele PL; van Hagen PM; Kuijpers RW; van den Bosch WA; Drexhage HA; Hooijkaas H; Dik WA
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1002-7. PubMed ID: 19797221
[TBL] [Abstract][Full Text] [Related]
13. Association between interleukin 21 and Graves' disease.
Jia HY; Zhang ZG; Gu XJ; Guo T; Cui B; Ning G; Zhao YJ
Genet Mol Res; 2011 Oct; 10(4):3338-46. PubMed ID: 22057994
[TBL] [Abstract][Full Text] [Related]
14. Role of poly (ADP-ribose) polymerase-1 and cytokines in acute renal injury in elderly Chinese patients with diabetes mellitus.
Cao L; Liu Y; Zhang L; Wei Y
Clin Interv Aging; 2017; 12():2039-2045. PubMed ID: 29238179
[TBL] [Abstract][Full Text] [Related]
15. Cytokines (interferon-γ and tumor necrosis factor-α)-induced nuclear factor-κB activation and chemokine (C-X-C motif) ligand 10 release in Graves disease and ophthalmopathy are modulated by pioglitazone.
Antonelli A; Ferrari SM; Fallahi P; Piaggi S; Paolicchi A; Franceschini SS; Salvi M; Ferrannini E
Metabolism; 2011 Feb; 60(2):277-83. PubMed ID: 20206950
[TBL] [Abstract][Full Text] [Related]
16.
Zhang M; Liu S; Xu J; Lv S; Fan Y; Zhang Y; Zhang Y; Wu Y; Su Y; Yu H; Song S; He J; Li H
Curr Eye Res; 2020 Jul; 45(7):888-895. PubMed ID: 31869260
[TBL] [Abstract][Full Text] [Related]
17. Predisposition to Graves' disease and Graves' ophthalmopathy by genetic variants of IL2RA.
Du J; Wang X; Tan G; Wei W; Zhou F; Liang Z; Li H; Yu H
J Mol Med (Berl); 2021 Oct; 99(10):1487-1495. PubMed ID: 34287665
[TBL] [Abstract][Full Text] [Related]
18. Poly(ADP-ribose) polymerase 1 inhibition prevents interleukin-1β-induced inflammation in human osteoarthritic chondrocytes.
Sun Y; Zhou L; Lv D; Liu H; He T; Wang X
Acta Biochim Biophys Sin (Shanghai); 2015 Jun; 47(6):422-30. PubMed ID: 25926140
[TBL] [Abstract][Full Text] [Related]
19. Soluble CTLA-4 receptor an immunological marker of Graves' disease and severity of ophthalmopathy is associated with CTLA-4 Jo31 and CT60 gene polymorphisms.
Daroszewski J; Pawlak E; Karabon L; Frydecka I; Jonkisz A; Slowik M; Bolanowski M
Eur J Endocrinol; 2009 Nov; 161(5):787-93. PubMed ID: 19734241
[TBL] [Abstract][Full Text] [Related]
20. Association of NFKB1 -94ins/del ATTG promoter polymorphism with susceptibility to and phenotype of Graves' disease.
Kurylowicz A; Hiromatsu Y; Jurecka-Lubieniecka B; Kula D; Kowalska M; Ichimura M; Koga H; Kaku H; Bar-Andziak E; Nauman J; Jarzab B; Ploski R; Bednarczuk T
Genes Immun; 2007 Oct; 8(7):532-8. PubMed ID: 17690684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
